ReviewClinical microbiology reviews2006
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.
Review in Clinical microbiology reviews, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 497 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
497 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,092 citations in OpenAlex.
- Outcomes and treatment for disseminated nocardiosis caused by Nocardia otitidiscaviarum: a systematic review.BMC infectious diseases · 2026Pooled it
- Clinical patterns, species-specific correlations, and therapeutic outcomes of nocardiosis in immunocompetent individuals: a systematic analysis based on literature.Annals of clinical microbiology and antimicrobials · 2026Pooled it
- Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022Pooled it
- Species-level identification of Nocardia spp. from clinical samples via intelligent analysis of Raman spectroscopic fingerprints.World journal of microbiology & biotechnology · 2026Article
- Article
- Nocardiosis: death from the ground.Journal of medicine and life · 2026Article
- Disseminated Nocardia brasiliensis causing septic arthritis in a patient with non-small cell lung adenocarcinoma: a case report.BMC infectious diseases · 2026Article
- Article
- Nocardia brasiliensis endophthalmitis initially misdiagnosed as uveitis: a case report.Journal of ophthalmic inflammation and infection · 2026Article
- Nocardia fodinahabitans sp. nov. isolated from underground hard coal mine waters shows biotechnological potential for degradation of aromatic hydrocarbons.Molecular genetics and genomics : MGG · 2026Article
- First Report ofAnimals : an open access journal from MDPI · 2026Article
- Synergistic and additive in vitro interactions of imipenem, trimethoprim-sulfamethoxazole, amikacin, and clofazimine against clinical isolates of Nocardia wallacei.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Soil to Sheath: Nocardia Flexor Tenosynovitis in an Immunocompetent Pottery Artist.Journal of hand surgery global online · 2026Article
- Isolation, Identification and Whole-Genome Sequencing of aAnimals : an open access journal from MDPI · 2026Article
- NCY-1 β-Lactamase Activity Correlates With Antimicrobial Susceptibility of a Clinical Strain of Nocardia cyriacigeorgica.MicrobiologyOpen · 2026Article
- SinonasalThe Canadian veterinary journal = La revue veterinaire canadienne · 2026Article
- A landscape of epidemiology and strain distribution ofBiosafety and health · 2026Article
- Whole-genome sequencing and analysis of Nocardia veterana isolates from keratitis patients.Molecular genetics and genomics : MGG · 2026Article
- Redefining the diagnostic pathway for pulmonary nocardiosis: The imperative for early metagenomic sequencing.World journal of radiology · 2026Article
- Multi-year population-based study of the clinical and epidemiological risk factors for mortality in nocardiosis: survival analysis from a large regional Canadian healthcare region.BMC infectious diseases · 2026Article
437 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent explosion of newly described species of Nocardia results from the impact in the last decade of newer molecular technology, including PCR restriction enzyme analysis and 16S rRNA sequencing. These molecular techniques have revolutionized the identification of the nocardiae by providing rapid and accurate identification of recognized nocardiae and, at the same time, revealing new species and a number of yet-to-be-described species. There are currently more than 30 species of nocardiae of human clinical significance, with the majority of isolates being N. nova complex, N. abscessus, N. transvalensis complex, N. farcinica, N. asteroides type VI (N. cyriacigeorgica), and N. brasiliensis. These species cause a wide variety of diseases and have variable drug susceptibilities. Accurate identification often requires referral to a reference laboratory with molecular capabilities, as many newer species are genetically distinct from established species yet have few or no distinguishing phenotypic characteristics. Correct identification is important in deciding the clinical relevance of a species and in the clinical management and treatment of patients with nocardial disease. This review characterizes the currently known pathogenic species of Nocardia, including clinical disease, drug susceptibility, and methods of identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.